Ethical Investment — What is It,and what are the Implications for Industry Funding of Research into Alternatives?

EIRIS (2000). www.caritasdata.co.uk/charity1/ch019381.htm.

Ward A. (2000). Ethical investing. Companies come under pressure to alter course. Financial Times, July 8, p. 8.

Russell W.M.S. , & Burch R.L. (1959). The Principles of Humane Experimental Technique, 238 pp. Potters Bar, UK: UFAW.

Balls M. , Goldberg A.M. , Fentem J.H. , Broadhead C.L. , Burch R.L. , Festing M.F.W. , Frazier J.M. , Hendriksen C.F.M. , Jennings M. , van der Kamp M.D.O. , Morton D.B. , Rowan A.N. , Russell C. , Russell W.M.S. , Spielmann H. , Stephens M.L. , Stokes W.S. , Straughan D.W. , Yager J.D. , Zurlo J. , & van Zutphen B.F.M. (1995). The Three Rs: The way forward. The report and recommendations of ECVAM workshop 11. ATLA 23, 838–866.

Balls M. , & Fentem J.H. (1994). The Fund for the Replacement of Animals in Medical Experiments (FRAME): 23 years of campaigning for the Three Rs. In Alternatives to Animal Testing. New Ways in the Biomedical Sciences, Trends and Progress (ed. Reinhardt C.A. ), pp. 45–55. Weinheim, Germany: VCH.

Combes R.D. (1997). FRAME and the pharmaceutical industry. ATLA 25, 61–66.